Brilliant Violet 605™ anti-mouse CD45 Antibody

Product Details

Verified Reactivity

Mouse

Antibody Type

Monoclonal

Host Species

Rat

Immunogen

Mouse thymus or spleen

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).

Preparation

The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 605™ under optimal conditions.

Concentration

µg sizes: 0.2 mg/mL
µL sizes: lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)

Storage & Handling

The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining with µg, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. For flow cytometric staining with µl, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 605™ excites at 405 nm and emits at 603 nm. The bandpass filter 610/20 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 605™ is a trademark of Sirigen Group Ltd.

Learn more about Brilliant Violet™.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.

Excitation Laser

Violet Laser (405 nm)

Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation³, complement-dependent cytotoxicity^1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)^4,6, Western blotting⁷, and spatial biology (IBEX)^10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)

1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
8. Liu F, et al. 2012. Blood. 119:3295. PubMed
9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed

Product Citations

1. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
2. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
3. Zhu Y, et al. 2022. Nat Commun. 13:4282. PubMed
4. Wu MJ, et al. 2022. Cancer Discov. 12:812. PubMed
5. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
6. Wong P, et al. 2021. STAR Protoc. 2:100262. PubMed
7. Dalmas E et al. 2017. Immunity. 47(5):928-942 . PubMed
8. Flamar AL, et al. 2020. Immunity. 52(4):606-619.e6.. PubMed
9. Dando SJ, et al. 2021. Invest Ophthalmol Vis Sci. 62:10. PubMed
10. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
11. Israelow B, et al. 2020. bioRxiv. . PubMed
12. Platt DJ, et al. 2021. Cell Reports. 35(6):109113. PubMed
13. Boyd DF, et al. 2020. Nature. 587:466. PubMed
14. Turner JA, et al. 2020. Immunity. 53:1202. PubMed
15. Khamissi FZ, et al. 2022. Sci Adv. 8:eabm5900. PubMed
16. Zou C, et al. 2020. Cell Rep. 33:108447. PubMed
17. Marinaccio C, et al. 2021. Cancer Discovery. 11(6):1398-1410. PubMed
18. Lee J, et al. 2020. Gut Microbes. 1:. PubMed
19. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
20. Chen J, et al. 2022. J Nanobiotechnology. 20:283. PubMed
21. Gao Y, et al. 2020. Nat Cell Biol. 1064:22. PubMed
22. Shao Y, et al. 2019. Diabetes. 68:2131. PubMed
23. Huai W, et al. 2019. J Exp Med. 216:772. PubMed
24. Chen JC et al. 2018. Cell systems. 7(1):92-103 . PubMed
25. Skibba ME, et al. 2021. Respir Res. 22:315. PubMed
26. AR P, et al. 2016. Circ Res. 118: 400-409. PubMed
27. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
28. Lu SX, et al. 2021. Cell. . PubMed
29. García Nores GD, et al. 2018. Nat Commun. 9:1970. PubMed
30. Grizotte–Lake M, et al. 2018. Immunity. 49:1103. PubMed
31. Sharma S, et al. 2015. J Immunol. 194:5529. PubMed
32. Zhang H, et al. 2020. Cancer Cell. 37(1):37-54.e9.. PubMed
33. Nording H, et al. 2021. Nat Commun. 12:3352. PubMed
34. Wang F, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:257. PubMed
35. Kuhn NF, et al. 2020. Nat Commun. 4.74375. PubMed
36. Celik H, et al. 2021. Cancer Discov. 11:3126. PubMed
37. Sharma D, et al. 2022. Commun Biol. 5:479. PubMed
38. Reddy A, et al. 2020. Cell. 183:62. PubMed
39. Payne K, et al. 2016. J Leukoc Biol. 100: 625 - 635. PubMed
40. Wagner JA, et al. 2020. Cell Rep. 31:107720. PubMed
41. Freemerman AJ, et al. 2019. J Immunol. 202:1265. PubMed
42. Grigoryan L, et al. 2022. NPJ Vaccines. 7:55. PubMed
43. Pishesha N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
44. Ganguly K, et al. 2022. Front Immunol. 13:930449. PubMed
45. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
46. Cortez-Toledo O, et al. 2017. PLoS One. 12(2):e0171268. PubMed
47. Scarneo SA, et al. 2022. Sci Rep. 12:18091. PubMed
48. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
49. Baik JE, et al. 2022. Clin Transl Med. 12:e758. PubMed
50. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
51. Reese B, et al. 2020. J Immunol. 205:3218. PubMed
52. Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed
53. Gkountela S et al. 2019. Cell. 176(1-2):98-112 . PubMed
54. Kakizaki M, Watanabe R 2017. Neuropathology. 10.1111/neup.12386. PubMed
55. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
56. Chen YG, et al. 2020. Molecular Cell. 76(1):96-109. PubMed
57. Wolf KG, et al. 2022. JVS Vasc Sci. 3:336. PubMed
58. Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed
59. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
60. Li J, et al. 2022. Nat Commun. 13:4032. PubMed
61. Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
62. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
63. Di Mitri D, et al. 2019. Cell Rep. 28:2156. PubMed
64. Bhattacharya A, et al. 2018. Neuropsychopharmacology. 43:2586. PubMed
65. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
66. Dulken BW, et al. 2019. Nature. 571:205. PubMed
67. Gyoneva S, et al. 2019. Life Sci Alliance. 2:e201900453. PubMed
68. Zhang Y, et al. 2019. Nat Commun. 10:3667. PubMed
69. Terp MG, et al. 2021. Mol Oncol. 15:3299. PubMed
70. Myers DR, et al. 2020. Front Immunol. 11:576310. PubMed
71. Ovadya Y, et al. 2018. Nat Commun. 9:5435. PubMed
72. Kang YH, et al. 2019. Nat Commun. 10:912. PubMed
73. McDonald LT, et al. 2017. PLoS One. 12:e0180724. PubMed
74. Olson CA, et al. 2021. Cell Host Microbe. 29:1378. PubMed
75. Ren J, et al. 2021. JCI Insight. 6:. PubMed
76. Harb H, et al. 2020. Nat Immunol. 1359:21. PubMed
77. Berrien–Elliott MM, et al. 2020. Immunity. 51(3):479-490. PubMed
78. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
79. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
80. Bennion BG, et al. 2019. J Virol. 93. PubMed
81. Zhu YP et al. 2018. Cell reports. 24(9):2329-2341 . PubMed
82. Pavelko K, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01532. PubMed
83. Fedele C, et al. 2021. J Exp Med. 218: . PubMed
84. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
85. Becattini S, et al. 2021. Cell Host Microbe. 29(3):378-393.e5. PubMed
86. Dai X, et al. 2021. Molecular Cell. 81(11):2317-2331.e6. PubMed
87. Molgora M, et al. 2020. Cell. 182:886. PubMed
88. Hong JP, et al. 2020. Cell Reports Medicine. 1(3):100035. PubMed
89. Teng F, et al. 2021. Cell Rep. 37:110051. PubMed
90. Li H, et al. 2022. iScience. 25:104481. PubMed
91. Dubrot J, et al. 2021. Immunity. 54(3):571-585.e6. PubMed
92. Castillo–Azofeifa D, et al. 2019. EMBO J. 38:e99984. PubMed
93. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
94. Perez-Cruz M, et al. 2021. PLoS One. e0236216:16. PubMed
95. Li Z et al. 2018. Immunity. 49(4):640-653 . PubMed
96. Lloyd AF, et al. 2019. Nat Neurosci. 1.643055556. PubMed
97. Shao Y, et al. 2019. Stem Cells. 37:1331. PubMed
98. Avgustinova A, et al. 2021. Cell Stem Cell. . PubMed
99. Kuhn NF et al. 2019. Cancer cell. 35(3):473-488 . PubMed

RRID

AB_2562341 (BioLegend Cat. No. 103139)
AB_2650656 (BioLegend Cat. No. 103155)
AB_2562342 (BioLegend Cat. No. 103140)

Antigen Details

Structure

Protein tyrosine phosphatase (PTP) family, 180-240 kD

Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function

Phosphatase, T and B cell activation

Ligand/Receptor

Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1

Cell Type

B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs

Biology Area

Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells

Molecular Family

CD Molecules

Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID

19264 View all products for this Gene ID

UniProt

View information about CD45 on UniProt.org

Documentation

• Technical Data Sheet (pdf)
• Certificate of Analysis
• Safety Data Sheet

Reviews

Related Protocols

• Cell Surface Flow Cytometry Staining Protocol

Related Pages & Pathways

Related FAQs

Other Formats

Certificate of Analysis